Bilcare Ltd
BSE:526853
Relative Value
The Relative Value of one BI stock under the Base Case scenario is 417.36 INR. Compared to the current market price of 64.39 INR, Bilcare Ltd is Undervalued by 85%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
BI Competitors Multiples
Bilcare Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
IN |
Bilcare Ltd
BSE:526853
|
1.5B INR | 0.2 | 6.4 | 12 | 34.8 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
220.8B USD | 5.1 | 36.8 | 22.7 | 33.3 | ||
US |
Danaher Corp
NYSE:DHR
|
180.7B USD | 4.1 | 22.4 | 16.3 | 20.1 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
40.6B USD | 2.8 | 29.9 | 16.6 | 25.6 | ||
US |
Agilent Technologies Inc
NYSE:A
|
40.4B USD | 6 | 32.7 | 26.1 | 31.4 | ||
CH |
Lonza Group AG
SIX:LONN
|
37B CHF | 5.5 | 56.5 | 19.4 | 28.5 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
55.2T KRW | 14.9 | 64.3 | 33.9 | 48.8 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
26.9B USD | 7.1 | 34.2 | 23.7 | 26.3 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.8B USD | 9.1 | 46.7 | 32.4 | 39.4 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
24.8B USD | 3 | 36.3 | 16.5 | 25.3 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
19B EUR | 7 | 74.5 | 32.4 | 53.1 |